PhRMA and BIO seek changes in FDA’s guidance to mitigate drug shortages
Last month, several pharma advocacy groups voiced both their approval and concerns with the FDA’s draft guidance concerning how to handle potential drug shortages …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
